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Introduction
Thyroidectomy is a common surgical procedure, mainly 
used to treat thyroid tumors or hyperthyroidism. However, 
because it sometimes results in complications such as 
laryngeal nerve palsy or hypoparathyroidism that lower 
patients’ quality of life, it can be a major trigger for medical 
lawsuits (1-4). As improvements in diagnostic methods 
have led to a significant increase in the early detection of 
thyroid cancer worldwide (5-7), medical disputes related to 
thyroid surgery are also likely to increase. Medical lawsuits 
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have economically and psychologically adverse effects on 
both physicians and patients, irrespective of the presence of 
medical malpractices (2). Accordingly, to protect surgeons 
from medical lawsuits and to ensure that patients have 
safer surgeries, efforts to prevent disputes in advance are 
necessary.
South Korea has one of the highest incidence rates of 
thyroid cancer worldwide (7). According to the Korea 
Central Cancer Registry, the incidence of thyroid cancer 
has increased more than tenfold, from 7.2 per 100,000 
people in 1999 to 74.7 per 100,000 people in 2012 (8). The 
incidence rate has declined slightly since 2013, but thyroid 
cancer is still one of the most common cancers in South 
Korea, and thyroidectomy is still frequently performed (9). 
With the country’s economic growth and improving 
awareness of people’s rights, the patient-physician 
relationship in South Korea has shifted from that of 
“paternalism”, where doctors are viewed as absolute 
authorities, to that of “reciprocity”, here patient autonomy 
is respected, as in other developed countries (10). To further 
strengthen patients’ rights, a mandate requiring physicians 
to explain to patients the various aspects of their treatment 
was added to the Medical Service Act in 2016. Accordingly, 
medical disputes are steadily increasing, and these are 
resolved through judicial methods such as civil lawsuits or 
non-judicial methods such as mediations (11). 
Among them, medical lawsuit judgments, which include 
information such as medical accident, patient’s allegations, 
and court decisions, are good tools for identifying the 
characteristics of medical disputes. Analyzing lawsuit 
judgments involving thyroidectomy in South Korea 
might produce meaningful results, but no such study 
has been conducted so far. The purpose of this study 
was to investigate the causes of medical disputes and the 
corresponding court decisions related to thyroidectomy, 
using lawsuit judgments in order to explore ways to prevent 
malpractice and unnecessary medical disputes. We present 
the following article in accordance with the MDAR and 
STROBE reporting checklist (available at http://dx.doi.
org/10.21037/gs-20-398).  
Methods
This study was a retrospective analysis that investigated all 
lawsuit cases involving thyroidectomy in South Korea from 
January 1998 to July 2019. We collected written judgments 
relating to thyroidectomy through the South Korean 
Supreme Court's written judgment database system. All 
judgments of the Supreme Court and the lower courts are 
databased in this system, and anyone can request copies of 
judgments they are seeking. These copies are provided to 
the requester after all personally identifiable information 
is deleted. Therefore, since it is impossible for researchers 
to collect personally identifiable information and identify 
individuals via this collection method, approval from a 
relevant institutional review board (IRB) was not necessary 
for this study. The study was conducted in accordance with 
the Declaration of Helsinki (as revised in 2013).
The terms “thyroidectomy” and “thyroid cancer” were 
used to identify and collect the desired written judgments. 
The contents of the judgments were then reviewed, and 
cases in which clinical information was insufficient for 
analysis and cases in which thyroidectomy was not actually 
performed but merely mentioned were excluded from our 
analysis. 
The judgments contain information such as the 
background of the disputes, information on the patients 
and defendants, the plaintiff’s allegations, and the court’s 
decisions. We collected information on the age and sex of 
the patient, pre/postoperative diagnoses, and the type of 
surgery from each case. Judicial information such as the type 
of defendant, lawsuit process, trial outcome, and payment 
amount were also collected. The plaintiff ’s allegations 
concerning the defendant’s malpractice were analyzed in 
two aspects: “treatment-related issues” and “explanation-
related issues”. “Treatment-related issues” were classified 
into four groups: misdiagnosis in the preoperative phase, 
misdiagnosis in the intraoperative phase, performance error 
in the intraoperative phase, and improper management in 
the postoperative phase. All analyses and classifications were 
performed independently by two researchers (S Choi and 
S Shin). In case of disagreements between the two, they 
went through a debate process for reaching consensus. If 
an agreement still could not be reached, a third researcher 
(S Kang) conducted additional analysis to confirm the final 
classification.
Statistical analysis
Descriptive statistical analyses were conducted using 
Microsoft Excel 2013 (Microsoft Corporation, Redmond, 
WA, USA) and IBM SPSS Statistics version 25 for windows 
(IBM Corporation, Armonk, NY, USA). Categorical 
variables were presented as frequencies and percentages. 
For continuous variables, we first performed the Shapiro-
Wilk test to check the data distribution (The distribution 
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was considered normal if P>0.05). If the continuous 
variables did not follow the normal distribution, these were 
presented as the median values and quartile ranges (IQR).
Results
We retrieved 192 lawsuit cases involving thyroidectomies 
from the database of the Korean Supreme Court written 
judgment system and excluded cases according to our 
selection criteria (Figure 1). After exclusion, 35 cases with 
54 lawsuit judgments were selected for this study. Of these, 
68.6% of patients were female and 68.6% were diagnosed 
with malignant disease before surgery (Table 1). Regarding 
surgery, 63.7% underwent total thyroidectomy and 87.9% 
underwent conventional open thyroidectomy. The judicial 
characteristics of the 35 cases are shown in Table 2. The 
most common type of defendant was “Medical institution 
only” (51.4%). In total, 19 cases (54.3%) were concluded at 
the first instance, and 20 (57.1%) were ruled in favor of the 
plaintiff. The average payment was $18,182 (USD) per case 
(with a range of $1,364 to $118,182).
Table 3 shows the plaintiff's allegation concerning 
treatment-related issues at each phase of surgery and the 
court’s decision. Of the 35 lawsuit cases, 33 were included 
and analyzed. In the preoperative phase, 10 cases claimed 
misdiagnosis due to “not examin(ing) fine needle aspiration 
cytology (FNAC)”, “misinterpretation of FNAC results”, 
or “failure to detect cancer despite examinations”. Of these, 
only 3 cases in which FNAC was not examined were ruled 
by the court as being due to physician malpractice; the 
tumor sizes were 3 to 4, 0.4, and 3.8 cm. Misdiagnosis at 
the intraoperative phase was associated with frozen section 
examination (FSE). Two cases showing “disregard for FSE 
results” were ruled by the court as being due to physician 
malpractice.
Of the 14 cases of alleged misdiagnosis (10 in the 
preoperative phase and 4 in the intraoperative phase), 12 
involved a conflict between preoperative and postoperative 
diagnoses, which became the main cause of the dispute 
(Table 4). Eight patients were diagnosed with malignant 
tumors or atypical cells before surgery, but their final 
postoperative diagnoses were benign tumors or thyroiditis 
that did not need thyroidectomy. Therefore, these eight 
claimed that “unnecessary surgery” had been caused either 
by the absence or the misinterpretation of FNAC or FSE 
results. Three patients claimed that there had been a 
“diagnosis delay” owing to the failure to detect cancer or 
lymph node metastasis despite preoperative examinations
There were 19 cases claiming “performance error” 
during the intraoperative phase; 5 cases of recurrent 
laryngeal nerve (RLN) injuries, 3 cases of arterial ruptures, 
and 1 case of sympathetic nerve injury were ruled by the 
court as being due to physician malpractice. Details of the 
9 malpractice cases are shown in Table 5. Regarding RLN 
injury, while all cases of bilateral injuries were ruled as 
being due to physician malpractice, only 50% of unilateral 
injury cases were ruled as such. The range of the awarded 
payment was $16,909 to $102,999. All alleged events 
regarding arterial ruptures were recognized as being caused 
by malpractice. The clinical outcomes caused by arterial 
rupture were death (n=2) or transient ischemic attack (n=1). 
All awarded payments were above the average amount 
($18,182). A patient who experienced sympathetic nerve 
injury due to excessive traction during surgery had Horner’s 
syndrome. The awarded payment was $12,475.
There were 10 cases claiming “improper management” 
in the postoperative phase. “Negligence in monitoring and 
emergency responses (n=2)” and “disregard for the patient’s 
symptoms of nerve injury (n=1)” were ruled by court as 
being due to physician malpractice.
Finally, we analyzed the alleged violation of liability 
for explanation. Figure 2 shows the cases ruled by the 
court as owing to the physician’s violation of liability for 
explanation. The most common case was the explanation 
of surgical complications (n=10). Among those 10 cases, 
the most common content was “vocal cord paralysis 
(n=5)”. There were 4 cases in which information about the 
patient’s condition was not provided and 4 cases in which 
insufficient information was provided about the potential 
Figure 1 Flowchart on the selection of lawsuit cases. 
Searching lawsuit judgments related to thyroidectomy
that the court ordered from January 1998 to July 2019
192 judgments were extracted
54 judgments (35 cases) were selected for study
138 judgments excluded 
• Judgments in which thyroidectomy was 
not performed (n=72)
• Judgments that overlapped (n=43)
• Judgments in which clinical information 
was insufficient for analysis (n=23)
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Table 1 Patient demographics and clinical information (n=35)
















Extent of surgery‡ (by or at defendant)
Total thyroidectomy 21 63.7
Lobectomy 8 24.2
Subtotal thyroidectomy 4 12.1
Type of surgical procedure‡ (by or at defendant)
Conventional open thyroidectomy 29 87.9
Robotic thyroidectomy 3 9.1
Endoscopic thyroidectomy 1 3.0
Main alleged adverse event or clinical outcome
Vocal cord palsy with RLN injury 7 20.0
Unnecessary surgery 7 20.0
Compressive neck hematoma 5 14.2
Delayed diagnosis 4 11.4
Hypoparathyroidism with parathyroid injury 3 8.5
Pulmonary thromboembolism 2 5.6
Cerebral infarction with carotid artery injury 1 2.9
Transient ischemic attack with carotid artery injury 1 2.9
Horner’s syndrome with sympathetic nerve injury 1 2.9
Dysphagia with accessory nerve injury 1 2.9
Cardiac dysfunction with vagal reflex 1 2.9
Neck muscle hardening 1 2.9
None 1 2.9
†, 4 hyperthyroidism, 1 Hashimoto’s thyroiditis; ‡, excludes 2 cases operated on at another hospital, not defendant. 
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Table 2 Judicial characteristics of the selected 35 cases
Variable No. Percent, %
Type of defendant
Physician only 2 5.7
Physician and medical institution 14 40.0
Medical institution only 18 51.4
Medical institution, physician, and nurse 1 2.9
Process of lawsuit
First instance 19 54.3
Appeal 13 37.1
Final appeal 3 8.6
Trial outcome
Ruled in favor of plaintiff 20 57.1










None (dismissal) 8 22.9
Payment amount (USD†)
Median $18,182 (IQR‡ = $10,202–$29,955)
Range (min to max) $1,364–$118,182
†, USD: United States Dollar, the exchange rate was 1 USD =1.100 KRW; ‡, IQR: interquartile range (Q1–Q3). 
benefits and risks of the procedures. There were 3 cases in 
which information about the possibility of misdiagnosis and 
limitations of preoperative examinations was not provided.
Discussion
This study analyzed lawsuits involving thyroidectomy 
and explored ways to prevent medical malpractice and 
unnecessary lawsuits. In this study, we found three main 
results. First, as in previous studies, RLN injury was one of 
the most common causes of lawsuits in Korea. Second, if 
surgeons followed guidelines, the court did not recognize 
misdiagnosis as medical malpractice. Third, informed 
consent was insufficient, although it is a basic medical duty 
to explain complications before surgery.
This study showed that the most common cause of 
lawsuits was “performance error during surgery”, and of 
these, RLN injury was the leading cause. This is consistent 
with previous studies in Germany and the United States 
(Table S1) (12-14). The court’s judgment on RLN injury 
differed depending on the extent of damage. All cases of 
bilateral injury were judged as malpractice; whereas in cases 
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Table 3 Alleged liability for treatment-related issues at each phase of surgery
Alleged liability for treatment-related issues at each phase of surgery
No. of cases
Recognition rate, %
Total† Recognition of the court
Preoperative phase
Misdiagnosis 10 3
Not performing FNAC 5 3 60.0
Misinterpretation of FNAC result 2 0 0.0
Failure to detect cancer 2 0 0.0
Others‡ 1 0 0.0
Intraoperative phase
Misdiagnosis 4 2
Disregard FSE result 3 2 66.7
Misinterpretation of FSE result 1 0 0.0
Performance error 19 9
RLN injury 7 5 71.4
Bilateral 3 3 100.0
Unilateral 4 2 50.0
Arterial rupture 3 3 100.0
Parathyroid injury 3 0 0.0
Negligence in hemostasis 3 0 0.0
Sympathetic nerve injury 1 1 100.0
Others § 2 0 0.0
Postoperative phase
Improper management 10 3
Negligence in monitoring and emergency response 5 2 40.0
Disregard for the symptoms of nerve injury 3 1 33.3
Others¶ 2 0 0.0
†, 10 lawsuit cases had more than 2 allegations, so there are more allegations than cases. ‡, only lesions were resected despite  
suspected lymph node metastasis. §, accessory nerve injury; negligence in preventing PTE. ¶, negligence in removing drain tube; urgency to  
discharge with quick removal of drain tube. FNAC, fine-needle aspiration cytology; FSE, frozen section examination; RLN, recurrent  
laryngeal nerve; PTE, pulmonary thromboembolism.
of unilateral injury, only 50% was judged as malpractice. 
This trend was the same in Germany (12), and studies in 
the United States and Italy also showed that the awarded 
amount for bilateral injuries was greater than that for 
unilateral injuries (2,14,15). These court decisions indicate 
that judges tend to regard unilateral injury as an unavoidable 
complication but bilateral injury as evidence of medical 
negligence. However, RLN injury, whether bilateral or 
unilateral, can be caused by other factors in spite of the 
surgeon’s best efforts (15). Therefore, when the courts 
judge the surgeon's negligence in cases of RLN injuries, 
whether bilateral or unilateral, it is necessary to consider 
fully the surgeon's efforts to prevent RLN injuries rather 
than only regarding the resultant nerve injury. The most 
basic technique surgeons can take to prevent RLN injury 
involves first identifying and observing the RLN during 
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surgery (16,17), and, second, recording the details of RLN 
preservation identified is necessary (12,14,18). For RLN 
identification, the use of intraoperative neurophysiologic 
monitoring (IONM) can be considered. Many reports 
demonstrate that IONM can help prevent RLN injury, 
especially bilateral injury (19-24). In Germany, according 
to Dralle, some disputes were caused by not using IONM 
in thyroidectomy or by not using IONM in accordance 
with international standards (12). However, so far no cases 
of dispute about the use of IONM have been reported in 
countries other than Germany (Table S1) (12-14,25,26). In 
South Korea, the introduction of IONM was relatively late, 
but the use of IONM will become gradually more common, 
because National Health Insurance benefits began covering 
laryngeal nerve monitoring in 2015 (27). Thus, it is 
advisable that surgeons more actively consider using IONM 
to prevent RLN injury during surgery, and they must 
document all actions taken to protect RLN during surgery 






Diagnosis Extent of surgery 
(year)
Court  





FNAC‡, CT PTC (0.4 cm) – Nodular  
hyperplasia





CT Multiple nodule  
(3.8 cm)





TFT, US, Scan, 
FNAC, CT









US, FNAC PTC (0.55 cm) Follicular  
adenoma
HTA TL (in 2012) X
Unnecessary 
surgery
Disregard for FSE 
result
TFT, FNAC, CT → 
after 5 months, US
PTC Thyroiditis Hashimoto’s  
Thyroiditis
TT (in 2009) O
Unnecessary 
surgery
Disregard for FSE 
result




TT (in 2010) O
Unnecessary 
surgery
Disregard for FSE 
result
US, FNAC → after  
3 months, FNAC
Indeterminate 











FNAC → after 1 
month, FNAC & CT











FNAC, CT PTC with LN  
enlargement
– Tumor without 
LNM







US Cancer (3–4 cm) – Cancer with 
LNM





Failure to detect 
cancer
US, FNAC Atypical cell – PTC § – X
Delayed  
diagnosis
Failure to detect 
cancer
US, Scan, FNAC → 
monthly US×3 → 
FNAC → monthly 
US×3 → FNAC → 
monthly US×2
Atypical nodule – PTC § – X
†, O: recognition of defendant’s malpractice; X: dismissal for claim. ‡, examination performed at another hospital before visiting the  
defendant (about 10 days prior). §, diagnosis in another hospital after visiting the defendant. US, ultrasonography; FNAC, fine-needle  
aspiration cytology; FSE, frozen section examination; TFT, thyroid function test; PTC, papillary thyroid carcinoma; TT, total thyroidectomy; 
TL, thyroid lobectomy; HTA, hyalinizing trabecular adenoma; LNM, lymph node metastasis. 
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to protect themselves from disputes.
In the cases of a misdiagnosis, the court judged that 
if the physicians diagnosed according to the guidelines, 
misdiagnosis was not the fault of the physicians, even if 
the diagnosis changed after the surgery. However, cases 
in which “FNAC was not performed before surgery” or 
in which “total thyroidectomy went ahead as planned 
even though the FSE result turned out non-cancer” were 
ruled as malpractice. These results have two implications. 
First, thyroidectomy is vulnerable above all to disputes 
involving diagnostic errors, because thyroid cancer, the 
main reason for thyroidectomy, is difficult to diagnose 
clearly before surgery due to the limitations of diagnostic 
testing techniques. Therefore, when deciding whether to 
undergo surgery, patients should be fully informed about 
the possibility that the tumor diagnosed as cancerous may 
turn out, after surgery, to be benign due to the limitations 
of preoperative examinations (28,29). Second, it would 
Table 5 Nine performance error cases ruled by the court as due to physician’s negligence 
Performance error Clinical outcome Age, years Trial outcome Payment (USD†)
Unilateral RLN injury VCP 42 Ruled in favor of plaintiff 102,999
Unilateral RLN injury VCP 38 Ruled in favor of plaintiff 50,000
Bilateral RLN injury VCP 48 Ruled in favor of plaintiff 80,492
Bilateral RLN injury VCP 42 Settlement decision 22,727
Bilateral RLN injury VCP N/I Ruled in favor of plaintiff 16,909
STA rupture Death due to compressive neck hematoma N/I Settlement decision 40,909
ICA rupture Death after cerebral infraction N/I Ruled in favor of plaintiff 26,364
CCA rupture Transient ischemic attack N/I Ruled in favor of plaintiff 31,818
Sympathetic nerve injury Horner’s syndrome N/I Ruled in favor of plaintiff 12,475
†, USD: United States Dollar, the exchange rate was 1 USD =1.100 KRW. STA, superior thyroid artery; CCA, common carotid artery; ICA, 
internal carotid artery; VCP, vocal cord paralysis; N/I, no information. 
Figure 2 Cases of violation of liability for explanation. †, two lawsuit cases had more than two contents so that there are more contents than 
cases.
• Extent of thyroidectomy (n=1) 










Pros and Cons 







• Limitation of FNAC (n=2) 
• Limitation of FSE (n=1) 
• Lymph node metastasis (n=2) 
• FSE results during surgery (n=2) 
• Vocal cord paralysis (n=5) 
• Hypoparathyroidism (n=2) 
• Carotid artery rupture (n=1) 
• Pulmonary thrombocmbolism (n=1) 
• Ptosis with Horner’s syndrome (n=1)
• Comparison of robotic with conventional open surgery (n=1) 
• Comparison of endoscopic with conventional open surgery (n=1) 
• Comparison of total thyroidectomy with lobectomy (n=1) 
• Comparison of surgery with non-operative treatment (n=1)
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be safer to adhere to standardized diagnostic criteria to 
mitigate legal responsibility for misdiagnosis. In 1996, the 
American Thyroid Association published its “Treatment 
guidelines for patients with thyroid nodules and thyroid 
cancer” (30), and in 2007, South Korean Thyroid 
Association published similar guidelines more reflective 
of its sociomedical situation (31). Since its release, both 
guidelines have been regularly revised. Regarding FNAC, 
there seems to be a need for more extensive use than the 
recommendation set out in the guideline. For example, 
in 2014, the guidelines in both the United States and 
South Korea suggested performing FNAC when tumor 
size was over 0.5 cm (32,33), but the court judged that 
FNAC should be performed even when tumor size was 
0.4 cm. In addition, the court judged that a re-examination 
should be performed, even though FNAC was previously 
performed at another hospital (Table 4). This situation is 
not unique to South Korea. According to Lydyiatt (34), 
the US court judged that the false-negative case of FNAC 
was not medical malpractice, while that “not performing 
FNAC” was medical malpractice. Therefore, performing 
FNAC more actively may be a way to prevent unnecessary 
lawsuits. In practice, guidelines are not strictly required 
standards but recommendations (35), so it is appropriate to 
apply them according to the individual patient’s condition 
or the judgment of the surgeon. On the other hands, in the 
case of FSE, in contrast to FNAC, there were no disputes 
arising out of cases when the surgeon did not perform the 
examination. The effectiveness of FSE is still controversial 
(36-38); therefore, conservative implementation of FSE may 
be a way to prevent disputes. Nevertheless, if the surgeon 
determines that the FSE is necessary, the surgeon should 
fully discuss with the patient and his family before surgery 
possible plans and scenarios according to FSE results that 
will be revealed during the surgery. Our study showed that 
the court regarded as malpractice if surgeon do not explain 
FSE result to the patient’s family during surgery or do not 
consider to narrow the extent of surgery even though FSE 
result turned out non-cancer during surgery. However, it 
is commonly impossible to explain FSE results to patients 
and their family during surgery. Therefore, it is important 
to obtain informed consent on surgery including FSE 
after fully explaining to patients both the reason that FSE 
is needed and the possible options according to the FSE 
results.
In this study, cases of physician’s violation of liability 
for explanation were various (Figure 2). Insufficient 
explanation may be the cause of dispute because it hinders 
the formation of trust with patients (39). Physicians should 
be aware that providing information to patients is the 
most fundamental obligation of the physician (40,41), and 
patients should only give informed consent to undergo 
surgery based on sufficient information. Shared decision-
making can be considered an effective method of providing 
an environment of self-determination for the patients 
(42,43). In shared decision-making, the physician provides 
sufficient non-biased information that the patient considers, 
and the final treatment direction is decided by the physician 
and patient together based on the patient’s values and 
preferences (42,43). Although this requires the physician to 
spend more time explaining and waiting for the patient to 
decide on the final direction of treatment, it is suitable for 
non-urgent surgeries such as thyroidectomy. Nevertheless, 
it is impossible to predict and explain all possible risks 
before surgery, because each patient's characteristics is 
different. Some disputes may arise even if informed consent 
is appropriately obtained before surgery. Therefore, 
building solid trust with patients may be the best way to 
prevent medical disputes. Various studies have shown that 
rapport formation, adequate communication, and good 
bedside manner help reduce medical disputes (44-46). 
This study has some limitations. First, as not all disputes 
go to court, the judgments we analyzed did not include 
all disputes related to thyroidectomy arising in South 
Korea. Thus, the results of this study may not fully reflect 
malpractice involving thyroidectomy. Second, the judgments 
did not contain detailed clinical information on patients and 
surgery; the collection of information was limited, making 
it difficult to access the analysis from multiple perspectives. 
Third, the results of this South Korean study may not be 
representative worldwide, as the characteristics of lawsuits 
for thyroidectomy may vary across countries according to 
their social and cultural backgrounds. Fourth, the number 
of judgments was small compared to previous studies 
(Table S1) (12-14,25,26), making it difficult to reflect all 
characteristics of thyroidectomy fully. 
Despite these limitations, the study is meaningful in 
being the first to deal with medical disputes in South Korea, 
which has the highest incidence of thyroid cancer worldwide 
and a high number of thyroid surgeries. This study will not 
only provide useful information about medical malpractice 
to doctors and practitioners involved in thyroid surgery but 
will also be used as a basis for preparing measures to prevent 
recurrence. 
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Supplementary
Table S1 Comparison of previous research analyzing claims related to thyroid surgery
Characteristics Dralle et al., 2012 Singer et al., 2012 Dent et al., 2017 Gartland et al., 2019 Wijekoon et al., 2019 Ours
Country Germany USA UK USA UK South Korea
Source Institutional expert 
opinions
Physicians  
Insurers Association of 
America malpractice 
claims database
NHS Litigation  
Authority  
database
Controlled Risk  
Insurance Company  
Strategies’ Comparative  
Benchmarking System 
malpractice claims  
database
NHS Litigation  
Authority database
Supreme court of  
Korea’s written  
judgment management 
system database
Covered period 1995 to 2010 1985 to 2008 1995.1 to 2012.7 1995 to 2015 2002.4 to 2016.11 1998.1 to 2019.7
Number of total cases 75 380 161 128 189 35
Alleged adverse event, n (%)†
Vocal cord palsy and/or RLN injury 43 (57.3) 55 (14.5) 33 (20.5) 39 (30.5) 12†† (6.3) 7 (20.0)
Hypocalcemia with hypoparathyroidism 21 (28.0) 9 (2.4) 6‡ (3.7) 10 (7.8) 3†† (1.6) 3 (8.6)
Unnecessary surgery N/I N/I 2§ (1.2) 5¶ (3.9) 16†† (8.5) 7 (20.0)
Delayed diagnosis N/I N/I 40 (24.8) N/I 22†† (11.6) 4 (11.4)
Bleeding/hematoma 7 (9.3) N/I N/I 18 (14.1) N/I 5 (14.3)
IONM for RLN 3 cases without  
using IONM were ruled 
as malpractice
No case on IONM No case on IONM No case on IONM No case on IONM No case on IONM
†, percentage of each alleged adverse event in total cases; ‡, low serum calcium; §, 1 incorrect surgery, 1 inappropriate surgery; ¶, wrong-side surgery; ††, number of cases for each alleged ad-
verse event out of 91 ‘successful cases’ in which the plaintiff was rewarded payment. NHS, National Health Service; RLN, recurrent laryngeal nerve; N/I, no information; IONM, intraoperative 
neural monitoring. 
